PAREXEL International Corporation (PRXL) : Kerrisdale Advisers scooped up 99,209 additional shares in PAREXEL International Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 506,838 shares of PAREXEL International Corporation which is valued at $29.7 Million.PAREXEL International Corporation makes up approximately 5.15% of Kerrisdale Advisers’s portfolio.
Other Hedge Funds, Including , Cantab Capital Partners Llp reduced its stake in PRXL by selling 168 shares or 1.97% in the most recent quarter. The Hedge Fund company now holds 8,350 shares of PRXL which is valued at $488,642. PAREXEL International Corporation makes up approx 0.13% of Cantab Capital Partners Llp’s portfolio.Hanson Doremus Investment Management reduced its stake in PRXL by selling 560 shares or 1.66% in the most recent quarter. The Hedge Fund company now holds 33,181 shares of PRXL which is valued at $1.9 Million. PAREXEL International Corporation makes up approx 0.90% of Hanson Doremus Investment Management’s portfolio.Cornerstone Capital Management Holdings. reduced its stake in PRXL by selling 1,500 shares or 4.73% in the most recent quarter. The Hedge Fund company now holds 30,192 shares of PRXL which is valued at $1.8 Million. PAREXEL International Corporation makes up approx 0.01% of Cornerstone Capital Management Holdings.’s portfolio.Commonwealth Of Pennsylvania Public School Empls Retrmt Sys reduced its stake in PRXL by selling 5,838 shares or 37.82% in the most recent quarter. The Hedge Fund company now holds 9,597 shares of PRXL which is valued at $561,616. PAREXEL International Corporation makes up approx 0.01% of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys’s portfolio.Dupont Capital Management Corp boosted its stake in PRXL in the latest quarter, The investment management firm added 64,524 additional shares and now holds a total of 79,324 shares of PAREXEL International Corporation which is valued at $4.8 Million. PAREXEL International Corporation makes up approx 0.11% of Dupont Capital Management Corp’s portfolio.
PAREXEL International Corporation opened for trading at $61.44 and hit $62.41 on the upside on Wednesday, eventually ending the session at $61.6, with a gain of 0.56% or 0.34 points. The heightened volatility saw the trading volume jump to 5,04,136 shares. Company has a market cap of $3,258 M.
On the company’s financial health, PAREXEL International Corporation reported $0.89 EPS for the quarter, based on the information available during the earnings call on Apr 27, 2016. Analyst had a consensus estimate of $0.89. The company had revenue of $527.10 million for the quarter, compared to analysts expectations of $523.31 million. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS.
Many Wall Street Analysts have commented on PAREXEL International Corporation. PAREXEL International Corporation was Upgraded by Sun Trust Rbsn Humphrey to ” Buy” on Mar 28, 2016.
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company which provides a range of expertise in clinical research clinical logistics medical communications consulting commercialization and advanced technology products and services to the pharmaceutical biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management data management epidemiology health economics/outcomes research pharmacovigilance medical communications clinical pharmacology patient recruitment clinical supply and drug logistics post-marketing surveillance medical imaging services electronic data capture systems clinical trial management systems Web-based portals and other product development tools and services.